Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/26/2003US6610304 Peptides having activity against HIV into liposomes of sufficient size for white blood cell internalization (e.g. greater than 150 nm and preferably approximately 250-400 nm.) has been shown to increase the activity of those MBPCs
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them
08/26/2003US6610298 Molecular conjugate comprising (a) a photosensitizer and (b) a targeting moiety, wherein the targeting moiety targets the conjugate to the intracellular pathogen or to an infected host cell.
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/26/2003CA2220063C Acellular pertussis vaccines and methods of preparation thereof
08/25/2003CA2419773A1 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/21/2003WO2003068946A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003WO2003068941A2 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003WO2003068820A1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068807A2 Echinocandin cyclic peptide derivatives
08/21/2003WO2003068797A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003WO2003068796A1 4’-c-cyano-2’-deoxypurine nucleosides
08/21/2003WO2003068794A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof
08/21/2003WO2003068793A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
08/21/2003WO2003068792A1 Process for producing erythromycin a derivative
08/21/2003WO2003068791A2 Macrolides with activity against methicillin-resistant staphylococcus aureus
08/21/2003WO2003068790A2 Macrolide antibacterial compounds
08/21/2003WO2003068770A1 R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE
08/21/2003WO2003068754A1 Therapeutic substituted indazole derivatives
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068270A1 Method of radio-labelling biomolecules
08/21/2003WO2003068258A1 7s immunoglobulin for treatment of choroidal neovascularisation_
08/21/2003WO2003068250A1 Compositions and methods for treatment of skin disorders
08/21/2003WO2003068245A1 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
08/21/2003WO2003068244A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068225A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
08/21/2003WO2003068223A1 Aryl ureas with raf kinase and angiogenesis inhibiting activity
08/21/2003WO2003068214A1 Novel preventive for infections
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003068195A1 Oral dosage form for controlled drug release
08/21/2003WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders
08/21/2003WO2003068169A2 Stabilized synthetic immunogen delivery system
08/21/2003WO2003068164A2 Dosing regimen for gemcitabine hcv therapy
08/21/2003WO2003068162A2 Modified fluorinated nucleoside analogues
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068142A2 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents
08/21/2003WO2003068140A2 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003WO2003067991A1 Compositions and methods for treatment of microbial infections
08/21/2003WO2003067988A1 Aqueous antiseptic based on bispyridiniumalkanes
08/21/2003WO2003060142A9 Compositions and methods for controlled release
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003039450A3 Improvements in or relating to inhibition of viruses
08/21/2003WO2003028738A3 Anti-infectious carbohydrates
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2003025176B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2003024404A3 Chemokines as adjuvants of immune response
08/21/2003WO2003018549A3 Bicyclic compounds as inhibitors of chemokine binding to us28
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003015708A8 Composition and method for treating hiv infection
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2003001887A3 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
08/21/2003WO2002102416A3 Antiviral glycoconjugates
08/21/2003WO2002102308A3 Pharmaceutical composition for the treatment of viral infection
08/21/2003WO2002094844A3 Antiviral nucleosides
08/21/2003WO2002088664A3 Control of compactability through crystallization
08/21/2003WO2002085384A3 Lubricious coatings for substrates
08/21/2003WO2002085311A3 Hcg formulation
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002055554A3 Antimicrobial peptides and derived metapeptides
08/21/2003WO2002050545A3 Compositions and methods involving staphylococcus aureus protein staau-r9
08/21/2003WO2002050536A3 Replication assay for detecting anti-viral substances
08/21/2003WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002036611A3 Immunomodulatory peptides derived from heat shock proteins and uses thereof
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002008446A9 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
08/21/2003WO2001060162A9 Cationic, amphipathic beta-sheet peptides and uses thereof
08/21/2003US20030158413 A thiochromane-7-carboxamide derivatives as Rho kinase enzyme inhibitor; nontoxic, anticancer agents
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158243 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158210 Amino acid ester containing azole antifungals
08/21/2003US20030158204 Diamino phenothiazine derivatives and composition comprising same
08/21/2003US20030158201 Method for treating septic shock
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158189 Non-steroidal antiinflammatory agents treating bone disorders, Crohn's disease, and inflammatory bowel disease, respiratory disorders such as chronic obstructive pulmonary disease, infections, autoimmune diseases
08/21/2003US20030158174 Crystalline 1-methylcarbapenem derivatives
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158152 Protease inhibitors and their pharmaceutical uses
08/21/2003US20030158150 Combination therapy to treat hepatitis B virus
08/21/2003US20030158149 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold
08/21/2003US20030158138 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide
08/21/2003US20030158136 Materials and methods relating to immune responses to fusion proteins
08/21/2003US20030158134 Use of HIV Tat protein or polynucleotide, HIV Nef protein or polynucleotide, HIV Tat protein or polynucleotide linked to HIV Nef protein or polynucleotide and HIV gpl20 protein or polynucleotide in manufacture of vaccine against hiv
08/21/2003US20030158122 For treatment of hyperlipidemia and blood coagulation disorders and to reduce levels of virus, bacteria, and endotoxins in blood stream
1 ... 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 ... 1798